• (CGEM) and the Role of Price-Sensitive Allocations news.stocktradersdaily.com Sun, 16 Nov 2025 08:52:02 GMT
• cullinan therapeutics provides corporate update and reports third quarter 2025 financial results ADVFN Wed, 12 Nov 2025 08:53:28 GMT
• Cullinan Therapeutics to Participate in Upcoming Investor Conferences and Host Analyst and Investor Event at 2025 ASH Annual Meeti... 富途牛牛 Wed, 12 Nov 2025 00:01:29 GMT
• Cullinan Therapeutics to Participate in Upcoming Investor GlobeNewswire Mon, 10 Nov 2025 12:00:00 GMT
• cullinan (nasdaq: cgem) to join stifel, guggenheim; ash 2025 event Stock Titan Mon, 10 Nov 2025 12:00:00 GMT
• CULLINAN ONCOLOGY Earnings Results: $CGEM Reports Quarterly Earnings Quiver Quantitative Thu, 06 Nov 2025 12:57:00 GMT
• cullinan therapeutics inc reports q3 2025 eps of -$0.77, beating estimates; strong cash position at $475.5 million GuruFocus Thu, 06 Nov 2025 12:50:13 GMT
• cullinan therapeutics provides corporate update and reports third quarter 2025 financial results The Manila Times Thu, 06 Nov 2025 12:07:35 GMT
• Cullinan sidelines pair of oncology assets amid expansion into autoimmune R&D Fierce Biotech Thu, 06 Nov 2025 08:00:00 GMT
• responsive playbooks and the cgem inflection news.stocktradersdaily.com Wed, 05 Nov 2025 07:36:02 GMT
• Cullinan (NASDAQ: CGEM) announces 69% ORR for CLN-049 in r/r AML; Phase 1 shows manageable safety Stock Titan Mon, 03 Nov 2025 14:11:00 GMT
• Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager... GlobeNewswire Mon, 03 Nov 2025 08:00:00 GMT
• Cullinan Therapeutics Shares Additional Preclinical B Cell GlobeNewswire Sat, 25 Oct 2025 07:00:00 GMT
• Cullinan (NASDAQ: CGEM) details CLN-978 data at ACR 2025; deep B cell depletion Stock Titan Sat, 25 Oct 2025 07:00:00 GMT
• Cullinan Therapeutics Presents Promising Preclinical Data for CLN-978 in Autoimmune Diseases at ACR Convergence 2025 Quiver Quantitative Sat, 25 Oct 2025 07:00:00 GMT
• Lynx1 capital buys Cullinan Therapeutics (CGEM) shares for $2.1m By Investing.com Investing.com UK Wed, 22 Oct 2025 07:00:00 GMT
• Lynx1 capital buys Cullinan Therapeutics (CGEM) shares for $2.1m Investing.com Tue, 21 Oct 2025 07:00:00 GMT
• cullinan therapeutics targets new solutions for nsclc mutations Traders Union Mon, 20 Oct 2025 14:15:11 GMT
• egfr inhibitor market expected to gain momentum through 2034, according to delveinsight | merus, cullinan oncology, taiho pharma, ... The Globe and Mail Mon, 20 Oct 2025 14:04:00 GMT
• understanding the setup: (cgem) and scalable risk news.stocktradersdaily.com Fri, 17 Oct 2025 05:30:02 GMT
• Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations Benzinga Mon, 13 Oct 2025 07:00:00 GMT
• Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain ... PR Newswire Sun, 12 Oct 2025 07:00:00 GMT
• Taiho Oncology, Cullinan: Zipalertinib 31.3% Intracranial ORR in NSCLC | CGEM Stock News Stock Titan Sun, 12 Oct 2025 07:00:00 GMT
• Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m Investing.com India Sat, 11 Oct 2025 07:00:00 GMT
• Lynx1 capital buys Cullinan Therapeutics (CGEM) shares worth $9.8m Investing.com Fri, 10 Oct 2025 07:00:00 GMT
• relapsed/refractory acute myeloid leukemia (aml) pipeline 2025: pioneering clinical developments by 50+ global leaders – delveinsi... Barchart.com Mon, 29 Sep 2025 07:00:00 GMT
• relapsed/refractory acute myeloid leukemia (aml) pipeline 2025: pioneering clinical developments by 50+ global leaders – delveinsi... Barchart.com Fri, 26 Sep 2025 14:52:00 GMT
• pathios therapeutics appoints jon wigginton, m.d., as non-executive director The Malaysian Reserve Thu, 25 Sep 2025 00:15:01 GMT
• BDTX vs. Cullinan Therapeutic: Which EGFR Challenger Is the Better Buy? Yahoo Finance Tue, 23 Sep 2025 07:00:00 GMT
• taiho oncology and cullinan therapeutics announce acceptance of abstracts for zipalertinib at the iaslc 2025 world conference on l... Nasdaq Mon, 15 Sep 2025 16:16:44 GMT
• Leading Biotech Cullinan Therapeutics to Share Targeted Therapy Pipeline at Stifel 2025 Immunology Forum Stock Titan Fri, 12 Sep 2025 07:00:00 GMT
• h.c. wainwright reiterates buy rating on cullinan oncology stock at $24 Investing.com Fri, 12 Sep 2025 07:00:00 GMT
• cullinan therapeutics to participate in fireside chat at the stifel 2025 virtual immunology and inflammation forum The Globe and Mail Fri, 12 Sep 2025 07:00:00 GMT
• cullinan therapeutics to participate in upcoming investor conferences 富途牛牛 Thu, 11 Sep 2025 19:28:36 GMT
• transcript : cullinan therapeutics, inc. presents at morgan stanley 23rd annual global healthcare conference, sep-10-2025 08 MarketScreener Wed, 10 Sep 2025 13:51:17 GMT
• cullinan, taiho’s nsclc hopeful shows ‘strong activity,’ clearing road to fda BioSpace Wed, 10 Sep 2025 07:00:00 GMT
• Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib at the IASLC 2025 World Conference on Lung Cancer PR Newswire Tue, 09 Sep 2025 07:00:00 GMT
• 27.4% Response Rate: Zipalertinib Shows Promise for Hard-to-Treat Lung Cancer with EGFR Mutations Stock Titan Tue, 09 Sep 2025 07:00:00 GMT
• H.C. Wainwright reiterates Buy rating on Cullinan Oncology stock at $24 Investing.com Fri, 05 Sep 2025 07:00:00 GMT
• critical review: cullinan therapeutics (nasdaq:cgem) versus soligenix (nasdaq:sngx) Defense World Tue, 26 Aug 2025 07:00:00 GMT
• cullinan therapeutics to participate in upcoming investor conferences The Manila Times Fri, 22 Aug 2025 07:00:00 GMT
• Cullinan Oncology stock gets Buy rating from H.C. Wainwright ahead of WCLC data Investing.com Thu, 21 Aug 2025 07:00:00 GMT
• Cullinan Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Thu, 21 Aug 2025 07:00:00 GMT
• biotech leader cullinan therapeutics sets stage for key updates at global healthcare conferences Stock Titan Thu, 21 Aug 2025 07:00:00 GMT
• cytokine market accelerates with immuno-oncology pipeline & openPR.com Tue, 12 Aug 2025 21:54:00 GMT
• egfr non-small cell lung cancer clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analy... Barchart.com Tue, 12 Aug 2025 07:00:00 GMT
• egfr non-small cell lung cancer clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analy... Barchart.com Mon, 11 Aug 2025 19:41:00 GMT
• william blair has pessimistic outlook of cgem q3 earnings Defense World Mon, 11 Aug 2025 09:55:40 GMT
• cullinan therapeutics (cgem) to release earnings on thursday Defense World Thu, 07 Aug 2025 11:50:36 GMT
• Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results GlobeNewswire Thu, 07 Aug 2025 07:00:00 GMT
• cullinan therapeutics announces phase 1 enrollment for cln-978 and strategic board appointments amid positive financial results Quiver Quantitative Thu, 07 Aug 2025 07:00:00 GMT
• cullinan therapeutics expands autoimmune pipeline with $510m war chest, multiple trial updates Stock Titan Thu, 07 Aug 2025 07:00:00 GMT
• cullinan therapeutics, inc. (nasdaq:cgem) given consensus rating of “buy” by brokerages Defense World Sun, 03 Aug 2025 12:55:07 GMT
• cullinan therapeutics to present updated zipalertinib data at iaslc 2025 world conference on lung cancer MSN Fri, 01 Aug 2025 10:28:10 GMT
• Cullinan Therapeutics to Present Updated Zipalertinib Data at IASLC 2025 World Conference on Lung Cancer Yahoo Finance Thu, 31 Jul 2025 07:00:00 GMT
• Taiho Oncology and Cullinan Therapeutics Announce Acceptance of Abstracts for Zipalertinib at the IASLC 2025 World Conference on L... PR Newswire Tue, 22 Jul 2025 07:00:00 GMT
• taiho oncology to present updated zipalertinib data in lung cancer Investing.com Tue, 22 Jul 2025 07:00:00 GMT
• breakthrough lung cancer treatment: zipalertinib trial results reveal new hope for hard-to-treat egfr mutations Stock Titan Tue, 22 Jul 2025 07:00:00 GMT
• cullinan therapeutics: betting on zipalertinib nda catalyst Seeking Alpha Wed, 16 Jul 2025 02:24:00 GMT
• Cullinan Therapeutics: Betting On Zipalertinib NDA Catalyst Seeking Alpha Tue, 15 Jul 2025 07:00:00 GMT
• cullinan therapeutics stock: betting on zipalertinib nda catalyst (nasdaq:cgem) Seeking Alpha Tue, 15 Jul 2025 07:00:00 GMT
• cullinan therapeutics: a biopharmaceutical company with a modality-agnostic approach to drug development AInvest Tue, 15 Jul 2025 07:00:00 GMT
• zipalertinib's nda submission: can cullinan therapeutics finally cash in on its breakthrough? AInvest Tue, 15 Jul 2025 07:00:00 GMT
• disc medicine appoints nadim ahmed to its board of directors The Manila Times Mon, 14 Jul 2025 07:00:00 GMT
• egfr + nsclc pipeline appears robust with 25+ key pharma companies actively working in the therapeutics segment | delveinsight The Globe and Mail Tue, 08 Jul 2025 07:00:00 GMT
• cullinan oncology stock rating reiterated at buy by clear street Investing.com Australia Fri, 04 Jul 2025 03:01:15 GMT
• cullinan oncology stock rating reiterated at buy by clear street Investing.com Thu, 03 Jul 2025 07:00:00 GMT
• cullinan therapeutics, inc.(nasdaqgs: cgem) dropped from russell 3000 growth index MarketScreener Mon, 30 Jun 2025 07:05:28 GMT
• cullinan therapeutics, inc.(nasdaqgs:cgem) dropped from russell microcap growth index MarketScreener Mon, 30 Jun 2025 07:00:00 GMT
• cullinan oncology acquires genrix’s bispecific t cell engagers targeting bcma and cd19 for autoimmune disease therapies geneonline.com Fri, 20 Jun 2025 06:22:46 GMT
• cullinan oncology acquires genrix t cell engagers targeting bcma and cd19 for autoimmune disease therapies geneonline.com Wed, 18 Jun 2025 02:52:03 GMT
• cullinan deals $712m to test genrix bispecific tce in autoimmune BioWorld MedTech Tue, 17 Jun 2025 07:00:00 GMT
• cullinan oncology acquires genrix’s bispecific t cell engager therapies targeting bcma and cd19 for autoimmune disease research geneonline.com Mon, 16 Jun 2025 21:08:04 GMT
• cullinan oncology acquires genrix’s bispecific t cell engager therapies targeting bcma and cd19 for autoimmune disease treatment geneonline.com Sun, 15 Jun 2025 16:06:57 GMT
• cullinan oncology acquires genrix t cell engagers targeting bcma and cd19 for autoimmune disease therapies geneonline.com Sat, 14 Jun 2025 07:00:00 GMT
• when (cgem) moves investors should listen news.stocktradersdaily.com Fri, 13 Jun 2025 13:56:00 GMT
• cullinan oncology acquires genrix’s t cell engagers targeting bcma and cd19 for autoimmune disease therapies geneonline.com Fri, 13 Jun 2025 07:00:00 GMT
• cullinan deals $712m to test genrix bispecific tce in autoimmune BioWorld MedTech Thu, 12 Jun 2025 07:00:00 GMT
• cullinan oncology acquires genrix’s bispecific t cell engager therapies targeting bcma and cd19 for autoimmune disease research geneonline.com Thu, 12 Jun 2025 03:03:24 GMT
• cullinan oncology acquires genrix’s bispecific t cell engager therapies targeting bcma and cd19 for autoimmune disease research geneonline.com Wed, 11 Jun 2025 07:00:00 GMT
• cullinan oncology acquires genrix t cell engagers targeting bcma and cd19 for autoimmune disease therapies geneonline.com Tue, 10 Jun 2025 07:00:00 GMT
• cullinan oncology partners with genrix to develop t cell engagers targeting bcma and cd19 for autoimmune diseases geneonline.com Mon, 09 Jun 2025 15:06:54 GMT
• the week in pharma: action, reaction and insight – week to june 6 The Pharma Letter Sun, 08 Jun 2025 07:00:00 GMT
• cullinan oncology acquires genrix’s bispecific t cell engager therapies targeting bcma and cd19 for autoimmune diseases geneonline.com Sat, 07 Jun 2025 14:07:24 GMT
• Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal BioPharma Dive Thu, 05 Jun 2025 07:00:00 GMT
• cullinan pens $700m pact for bcma bispecific to pair with another autoimmune t-cell engager Fierce Biotech Thu, 05 Jun 2025 07:00:00 GMT
• cullinan oncology secures $712 million deal with genrix for bcma and cd19 bispecific t cell engagers geneonline.com Thu, 05 Jun 2025 07:00:00 GMT
• transcript : cullinan therapeutics, inc. - special call MarketScreener Thu, 05 Jun 2025 03:05:21 GMT
• cullinan licenses rights to velinotamig from genrix bio for $20m upfront TipRanks Wed, 04 Jun 2025 20:43:15 GMT
• Cullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, from Genrix Bio fo... GlobeNewswire Wed, 04 Jun 2025 07:00:00 GMT
• cullinan's $712m deal brings revolutionary bcma t cell therapy to autoimmune disease treatment Stock Titan Wed, 04 Jun 2025 07:00:00 GMT
• transcript : cullinan therapeutics, inc. - special call MarketScreener Wed, 04 Jun 2025 07:00:00 GMT
• transcript : cullinan therapeutics, inc. - shareholder/analyst call marketscreener.com Mon, 02 Jun 2025 06:24:33 GMT
• cullinan therapeutics inc - taiho oncology and cullinan therapeutics publish positive rezilient1 trial results MarketScreener Sun, 01 Jun 2025 12:25:38 GMT
• Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology PR Newswire Sun, 01 Jun 2025 07:00:00 GMT
• cullinan therapeutics to host analyst and investor event at 2025 asco annual meeting and participate in jefferies 2025 global heal... Yahoo Finance Thu, 29 May 2025 07:00:00 GMT
• ASCO: Cullinan, Taiho unveil lung cancer data behind FDA application plans Fierce Biotech Thu, 22 May 2025 07:00:00 GMT
• Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial... GlobeNewswire Thu, 22 May 2025 07:00:00 GMT
• taiho oncology presents data at the 2025 american society of clinical oncology annual meeting PR Newswire Thu, 22 May 2025 07:00:00 GMT
• (cgem) pivots trading plans and risk controls news.stocktradersdaily.com Wed, 21 May 2025 16:54:00 GMT
• ubs adjusts price target on cullinan therapeutics to $24 from $30, maintains buy rating marketscreener.com Mon, 12 May 2025 13:56:15 GMT
• when the price of (cgem) talks, people listen news.stocktradersdaily.com Sun, 11 May 2025 06:18:00 GMT
• cullinan therapeutics provides corporate update and reports first quarter 2025 financial results GlobeNewswire Fri, 09 May 2025 00:00:25 GMT
• cullinan therapeutics provides corporate update and reports first quarter 2025 financial results GlobeNewswire Thu, 08 May 2025 07:00:00 GMT
• cullinan oncology (cgem) projects financial runway through 2028 GuruFocus Thu, 08 May 2025 07:00:00 GMT
• cullinan therapeutics (cgem) advances autoimmune and oncology pr GuruFocus Thu, 08 May 2025 00:47:33 GMT
• cullinan therapeutics launches sjögren’s disease study Investing.com Tue, 29 Apr 2025 07:00:00 GMT
• cullinan therapeutics to initiate us study of cln-978 for moderate to severe sjogren's disease marketscreener.com Tue, 29 Apr 2025 07:00:00 GMT
• Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung C... GlobeNewswire Wed, 23 Apr 2025 07:00:00 GMT
• cullinan therapeutics to present positive rezilient1 study results of zipalertinib for nsclc at 2025 asco annual meeting Quiver Quantitative Wed, 23 Apr 2025 07:00:00 GMT
• taiho oncology to share data in five presentations, including two oral presentations, at the 2025 american society of clinical onc... PR Newswire Wed, 23 Apr 2025 07:00:00 GMT
• cullinan therapeutics (cgem) to present promising lung cancer st GuruFocus Wed, 23 Apr 2025 07:00:00 GMT
• Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T C... GlobeNewswire Wed, 16 Apr 2025 07:00:00 GMT
• ema greenlights cullinan’s arthritis drug trial in europe by investing.com Investing.com India Wed, 16 Apr 2025 07:00:00 GMT
• learn to evaluate (cgem) using the charts news.stocktradersdaily.com Tue, 15 Apr 2025 12:08:00 GMT
• Cullinan Therapeutics: Attractive Pipeline Progress, But We Will Wait For Complete Phase 2b Data Seeking Alpha Tue, 08 Apr 2025 07:00:00 GMT
• cullinan oncology stock hits 52-week low at $7.82 Investing.com Australia Tue, 01 Apr 2025 07:00:00 GMT
• cullinan oncology stock hits 52-week low at $7.82 by investing.com Investing.com Canada Mon, 31 Mar 2025 07:00:00 GMT
• (cgem) technical pivots with risk controls news.stocktradersdaily.com Sun, 09 Mar 2025 00:02:00 GMT
• (cgem) technical pivots with risk controls news.stocktradersdaily.com Sat, 08 Mar 2025 08:00:00 GMT
• cullinan therapeutics: promising pipeline and upcoming catalysts justify buy rating TipRanks Fri, 07 Mar 2025 12:29:44 GMT
• cullinan therapeutics’ chief medical officer sells $41,754 in stock Investing.com India Fri, 28 Feb 2025 08:00:00 GMT
• cullinan therapeutics reports 2024 financial results and updates TipRanks Fri, 28 Feb 2025 05:08:25 GMT
• cullinan therapeutics ceo sells $106,872 in stock by investing.com Investing.com Canada Fri, 28 Feb 2025 00:42:27 GMT
• cullinan therapeutics’ chief medical officer sells $41,754 in stock by investing.com Investing.com UK Thu, 27 Feb 2025 22:04:00 GMT
• Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results GlobeNewswire Thu, 27 Feb 2025 08:00:00 GMT
• Cullinan Therapeutics Reports Phase 1 Study Updates and Financial Results for Q4 2024 Nasdaq Thu, 27 Feb 2025 08:00:00 GMT
• cullinan therapeutics ceo sells $106,872 in stock by investing.com Investing.com Nigeria Thu, 27 Feb 2025 08:00:00 GMT
• brief-cullinan oncology q4 pretax profit usd -47.53 million TradingView Thu, 27 Feb 2025 08:00:00 GMT
• cullinan therapeutics' chief medical officer sells $41,754 in stock Investing.com Thu, 27 Feb 2025 08:00:00 GMT
• cullinan therapeutics reports 2024 financial results and updates TipRanks Thu, 27 Feb 2025 08:00:00 GMT
• financial review: cullinan therapeutics (nasdaq:cgem) and adaptimmune therapeutics (nasdaq:adap) Defense World Wed, 26 Feb 2025 08:00:00 GMT
• exclusive access: cullinan therapeutics leadership reveals strategy at elite healthcare forums StockTitan Mon, 24 Feb 2025 12:00:00 GMT
Cullinan Oncology, Inc(NASDAQ:CGEM) 
Cullinan Management, Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalati...
Website: https://www.cullinanoncology.com/
Founded: 2016
CEO: Owen Hughes
Sector: Pharmaceuticals
Industry:
Share this website to your friends